The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription

Gene

Volumn 219, Issue 1-2, 1998, Pages 25-35

  Rosin Arbesfeld, Rina ^a   Willbold, Dieter ^b   Yaniv, Abraham ^a   Gazit, Arnona ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Lentiviruses; Polyadenylation; TAR

Indexed keywords

TRANSACTIVATOR PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; RNA PROCESSING;

ANIMALS; CELL-FREE SYSTEM; DNA PRIMERS; DOGS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; GENES, TAT; HORSES; MUTAGENESIS, SITE-DIRECTED; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, VIRAL; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; RNA VIRUSES;

EID: 0032575915     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00389-8     Document Type: Article

References (40)

1. Ashe M.P., Griffin P., James W., Proudfoot N.J. Poly(A) site selection in the provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev. 9:1995;3008-3025.
2. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 41:1985;521-526.
3. Carvalho M., Derse D. Mutational analysis of the equine infectious anemia virus Tat-responsive element. J. Virol. 65:1991;3468-3474.
4. Cherrington J., Ganem D. Regulation of polyadenylation in human immunodeficiency virus (HIV): contributions of promoter proximity and upstream sequences. EMBO J. 11:1992;1513-1524.
5. Cleavinger P., Kandala J.C., Guntaka R.V. Sequences in the U5 region of Rous sarcoma virus LTR are required for transcription termination and polyadenylation. Cell. Biochem. Suppl. 15G:1991;246.
6. de la Luna S., Soria I., Pulido D., Ortin J., Jimenez A. Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene. 62:1988;121-126.
7. DeZazzo J.D., Falck-Pedersen E., Imperiale M.J. Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit. Mol. Cell. Biol. 11:1991;5977-5984.
8. Dorn P., DaSilva L., Martarano L., Derse D. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J. Virol. 64:1990;1616-1624.
9. Gilmartin G.M., Fleming E.S., Oetjen J. Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR. EMBO J. 11:1992;4419-4428.
10. Graeble M.A., Churcher M.J., Lowe A.D., Gait M.J., Karn J. Human immunodeficiency virus type 1 transactivator protein, Tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc. Natl. Acad. Sci. USA. 90:1993;6184-6188.
11. Graveley B.R., Gilmartin G.M. A common mechanism for the enhancement of mRNA 3′ processing by U3 sequences in two distantly related lentiviruses. J. Virol. 70:1996;1612-1617.
12. Guntaka R.V. Transcription termination and polyadenylation in retroviruses. Microbiol. Rev. 57:1993;511-521.
13. Herman S.A., Coffin J.M. Efficient packaging of read-through RNA in ALV: implications for oncogene transduction. Science. 236:1987;845-848.
14. Iwasaki K., Temin H.M. The efficiency of RNA 3′-end formation is determined by the distance between the cap site and the poly(A) site in spleen necrosis virus. Genes Dev. 4:1990;2299-2307.
15. Katz R.A., Skalka A.M. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:1990;409-445.
16. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S.R., Aaronson S.A. Nucleotide sequence analysis of equine infectious anemia proviral DNA. Virology. 158:1987;300-312.
17. Keller W. No end yet to messenger RNA 3′ processing. Cell. 81:1995;829-832.
18. King W., Patel M.D., Lobel L.I., Goff S.P., Nguyen-Huu M.C. Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science. 228:1985;554-558.
19. MacGregor, G.R., Nolan G.P., Fiering, S., Roederer, M., Herzenberg, L.A., 1989. Use of E. coli lacZ (β-galactosidase) as a reporter gene. Methods in molecular biology. In: Murray, E.J. (Ed.), Gene Expression In Vivo. Humana Press, Clifton, NJ, Vol. 7, pp. 217-235.
20. Mooslehner K., Karls U., Harbers K. Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J. Virol. 64:1990;3056-3058.
21. Noiman S., Yaniv A., Sherman L., Tronick S.R., Gazit A. Pattern of transcription of the genome of equine infectious anemia virus. J. Virol. 64:1990;1839-1843.
22. Noiman S., Yaniv A., Tsach T., Miki T., Tronick S.R., Gazit A. The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Virology. 184:1991;521-530.
23. Norton P.A., Coffin J.M. Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol. Cell. Biol. 5:1985;281-290.
24. Pridmore R.D. New and versatile cloning vectors with kanamycin-resistance marker. Gene. 65:1987;309-312.
25. Proudfoot N. Poly(A) signals. Cell. 64:1991;671-674.
26. Raineri I., Soler M., Senn H.P. Analysis of human immunodeficiency virus type 1 promoter insertion in vivo. Virology. 208:1995;359-364.
27. Rohdewohld H., Weiher H., Reik W., Jaenisch R., Breindl M. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J. Virol. 61:1987;336-343.
28. Rosin-Arbesfeld R., Rivlin M., Noiman S., Mashiah P., Yaniv A., Miki T., Tronick S.R., Gazit A. Structure and function characterization of rev-like transcripts of equine infectious anemia virus. J. Virol. 67:1993;5640-5646.
29. Rosin-Arbesfeld R., Mashiah P., Willbold D., Rosch P., Tronick S.R., Yaniv A., Gazit A. Biological activity and intracellular location of the Tat protein of equine infectious anemia virus. Gene. 150:1994;307-311.
30. Scott J.M., Imperiale M.J. Reciprocal effects of splicing and polyadenylation on human immunodeficiency virus type 1 pre-mRNA processing. Virology. 224:1996;498-509.
31. Shih C.C., Stoye J.P., Coffin J.M. Highly preferred targets for retrovirus integration. Cell. 53:1988;531-537.
32. Swain A., Coffin J.M. Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation. J. Virol. 63:1989;3301-3306.
33. Swain A., Coffin J.M. Mechanism of transduction by retroviruses. Science. 255:1992;841-845.
34. Swain A., Coffin J.M. Influence of sequences in the long terminal repeat and flanking cell DNA on polyadenylation of retroviral transcripts. J. Virol. 67:1993;6265-6269.
35. Vallejo A.N., Pogulis R.J., Pease L.R. In vitro synthesis of novel genes: mutagenesis and recombination by PCR. PCR Meth. Appl. 4:1994;S123-S130.
36. Valsamakis A., Zeichner S., Carswell S., Alwine J.C. The human immunodeficiency virus type 1 polyadenylation signal: a 3′ long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylation. Proc. Natl. Acad. Sci. USA. 88:1991;2108-2112.
37. Vider B.-Z., Zimber A., Hirsch D., Estlein D., Chastre E., Prevot S., Gespach C., Yaniv A., Gazit A. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem. Biophys. Res. Commun. 232:1997;742-748.
38. Wahle E. 3′-end cleavage and polyadenylation of mRNA precursors. Biochim. Biophys. Acta. 1261:1995;183-194.
39. Weichs an der Glon C., Monks J., Proudfoot N.J. Occlusion of the HIV poly(A) site. Genes Dev. 5:1991;244-253.
40. Weichs an der Glon C., Ashe M., Eggermont J., Proudfoot N.J. Tat-dependent occlusion of the HIV poly(A) site. EMBO J. 12:1993;2119-2212.